Microbial Database, Sequencing and Identification Services
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
176
NCT01243502
A Study to Assess the Pharmacokinetics, Safety and Tolerability of CT327 in Healthy Male Volunteers
Phase: Phase 1
Role: Collaborator
Start: Sep 30, 2007
Completion: Nov 30, 2007
NCT05877430
Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer
Phase: Phase 1/2
Role: Lead Sponsor
Start: Sep 11, 2023
Completion: Oct 31, 2027
Loading map...